Cargando…
Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice
BACKGROUND: Neuroinflammation often results in enduring cognitive impairment and is a risk factor for postoperative cognitive dysfunction. There are currently no effective treatments for infection-induced cognitive impairment. Previous studies have shown that the iron chelator deferoxamine (DFO) can...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323121/ https://www.ncbi.nlm.nih.gov/pubmed/25644393 http://dx.doi.org/10.1186/s12974-015-0238-3 |
_version_ | 1782356496477061120 |
---|---|
author | Zhang, Xiao-Ying Cao, Jiang-Bei Zhang, Li-Ming Li, Yun-Feng Mi, Wei-Dong |
author_facet | Zhang, Xiao-Ying Cao, Jiang-Bei Zhang, Li-Ming Li, Yun-Feng Mi, Wei-Dong |
author_sort | Zhang, Xiao-Ying |
collection | PubMed |
description | BACKGROUND: Neuroinflammation often results in enduring cognitive impairment and is a risk factor for postoperative cognitive dysfunction. There are currently no effective treatments for infection-induced cognitive impairment. Previous studies have shown that the iron chelator deferoxamine (DFO) can increase the resistance of neurons to injury and disease by stimulating adaptive cellular stress responses. However, the impact of DFO on the cognitive sequelae of neuroinflammation is unknown. METHODS: A mouse model of lipopolysaccharide (LPS)-induced cognitive impairment was established to evaluate the neuroprotective effects of DFO against LPS-induced memory deficits and neuroinflammation. Adult C57BL/6 mice were treated with 0.5 μg of DFO 3 days prior to intracerebroventricular microinjection of 2 μg of LPS. Cognitive function was assessed using a Morris water maze from post-injection days 1 to 3. Animal behavioral tests, as well as pathological and biochemical assays were performed to evaluate the LPS-induced hippocampal damage and the neuroprotective effect of DFO. RESULTS: Treatment of mice with LPS resulted in deficits in cognitive performance in the Morris water maze without changing locomotor activity, which were ameliorated by pretreatment with DFO. DFO prevented LPS-induced microglial activation and elevations of IL-1β and TNF-α levels in the hippocampus. Moreover, DFO attenuated elevated expression of caspase-3, modulated GSK3β activity, and prevented LPS-induced increases of MDA and SOD levels in the hippocampus. DFO also significantly blocked LPS-induced iron accumulation and altered expression of proteins related to iron metabolism in the hippocampus. CONCLUSIONS: Our results suggest that DFO may possess a neuroprotective effect against LPS-induced neuroinflammation and cognitive deficits via mechanisms involving maintenance of less brain iron, prevention of neuroinflammation, and alleviation of oxidative stress and apoptosis. |
format | Online Article Text |
id | pubmed-4323121 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43231212015-02-11 Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice Zhang, Xiao-Ying Cao, Jiang-Bei Zhang, Li-Ming Li, Yun-Feng Mi, Wei-Dong J Neuroinflammation Research BACKGROUND: Neuroinflammation often results in enduring cognitive impairment and is a risk factor for postoperative cognitive dysfunction. There are currently no effective treatments for infection-induced cognitive impairment. Previous studies have shown that the iron chelator deferoxamine (DFO) can increase the resistance of neurons to injury and disease by stimulating adaptive cellular stress responses. However, the impact of DFO on the cognitive sequelae of neuroinflammation is unknown. METHODS: A mouse model of lipopolysaccharide (LPS)-induced cognitive impairment was established to evaluate the neuroprotective effects of DFO against LPS-induced memory deficits and neuroinflammation. Adult C57BL/6 mice were treated with 0.5 μg of DFO 3 days prior to intracerebroventricular microinjection of 2 μg of LPS. Cognitive function was assessed using a Morris water maze from post-injection days 1 to 3. Animal behavioral tests, as well as pathological and biochemical assays were performed to evaluate the LPS-induced hippocampal damage and the neuroprotective effect of DFO. RESULTS: Treatment of mice with LPS resulted in deficits in cognitive performance in the Morris water maze without changing locomotor activity, which were ameliorated by pretreatment with DFO. DFO prevented LPS-induced microglial activation and elevations of IL-1β and TNF-α levels in the hippocampus. Moreover, DFO attenuated elevated expression of caspase-3, modulated GSK3β activity, and prevented LPS-induced increases of MDA and SOD levels in the hippocampus. DFO also significantly blocked LPS-induced iron accumulation and altered expression of proteins related to iron metabolism in the hippocampus. CONCLUSIONS: Our results suggest that DFO may possess a neuroprotective effect against LPS-induced neuroinflammation and cognitive deficits via mechanisms involving maintenance of less brain iron, prevention of neuroinflammation, and alleviation of oxidative stress and apoptosis. BioMed Central 2015-02-03 /pmc/articles/PMC4323121/ /pubmed/25644393 http://dx.doi.org/10.1186/s12974-015-0238-3 Text en © Zhang et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Zhang, Xiao-Ying Cao, Jiang-Bei Zhang, Li-Ming Li, Yun-Feng Mi, Wei-Dong Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice |
title | Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice |
title_full | Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice |
title_fullStr | Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice |
title_full_unstemmed | Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice |
title_short | Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice |
title_sort | deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323121/ https://www.ncbi.nlm.nih.gov/pubmed/25644393 http://dx.doi.org/10.1186/s12974-015-0238-3 |
work_keys_str_mv | AT zhangxiaoying deferoxamineattenuateslipopolysaccharideinducedneuroinflammationandmemoryimpairmentinmice AT caojiangbei deferoxamineattenuateslipopolysaccharideinducedneuroinflammationandmemoryimpairmentinmice AT zhangliming deferoxamineattenuateslipopolysaccharideinducedneuroinflammationandmemoryimpairmentinmice AT liyunfeng deferoxamineattenuateslipopolysaccharideinducedneuroinflammationandmemoryimpairmentinmice AT miweidong deferoxamineattenuateslipopolysaccharideinducedneuroinflammationandmemoryimpairmentinmice |